Zurbriggen R - Search Results

1

A new and versatile virosomal antigen delivery system to induce cellular and humoral immune responses.

Kammer AR, Amacker M, Rasi S, Westerfeld N, Gremion C, Neuhaus D, Zurbriggen R. Kammer AR, et al. Among authors: zurbriggen r. Vaccine. 2007 Oct 10;25(41):7065-74. doi: 10.1016/j.vaccine.2007.07.052. Epub 2007 Aug 14. Vaccine. 2007. PMID: 17766014

2

Peptide-loaded chimeric influenza virosomes for efficient in vivo induction of cytotoxic T cells.

Amacker M, Engler O, Kammer AR, Vadrucci S, Oberholzer D, Cerny A, Zurbriggen R. Amacker M, et al. Among authors: zurbriggen r. Int Immunol. 2005 Jun;17(6):695-704. doi: 10.1093/intimm/dxh249. Epub 2005 Apr 20. Int Immunol. 2005. PMID: 15843436

3

Peptides delivered by immunostimulating reconstituted influenza virosomes.

Westerfeld N, Zurbriggen R. Westerfeld N, et al. Among authors: zurbriggen r. J Pept Sci. 2005 Nov;11(11):707-12. doi: 10.1002/psc.700. J Pept Sci. 2005. PMID: 16059967 Review.

4

Efficient induction of tumoricidal cytotoxic T lymphocytes by HLA-A0201 restricted, melanoma associated, L(27)Melan-A/MART-1(26-35) peptide encapsulated into virosomes in vitro.

Schumacher R, Amacker M, Neuhaus D, Rosenthal R, Groeper C, Heberer M, Spagnoli GC, Zurbriggen R, Adamina M. Schumacher R, et al. Among authors: zurbriggen r. Vaccine. 2005 Dec 1;23(48-49):5572-82. doi: 10.1016/j.vaccine.2005.07.099. Epub 2005 Aug 15. Vaccine. 2005. PMID: 16165256

5

Optimized Malaria-antigens delivered by immunostimulating reconstituted influenza virosomes.

Westerfeld N, Pluschke G, Zurbriggen R. Westerfeld N, et al. Among authors: zurbriggen r. Wien Klin Wochenschr. 2006;118(19-20 Suppl 3):50-7. doi: 10.1007/s00508-006-0684-0. Wien Klin Wochenschr. 2006. PMID: 17131241 Review.

6

Contribution of influenza immunity and virosomal-formulated synthetic peptide to cellular immune responses in a phase I subunit malaria vaccine trial.

Peduzzi E, Westerfeld N, Zurbriggen R, Pluschke G, Daubenberger CA. Peduzzi E, et al. Among authors: zurbriggen r. Clin Immunol. 2008 May;127(2):188-97. doi: 10.1016/j.clim.2008.01.012. Epub 2008 Mar 11. Clin Immunol. 2008. PMID: 18337175 Clinical Trial.

7

Respiratory syncytial virus subunit vaccine based on a recombinant fusion protein expressed transiently in mammalian cells.

Nallet S, Amacker M, Westerfeld N, Baldi L, König I, Hacker DL, Zaborosch C, Zurbriggen R, Wurm FM. Nallet S, et al. Among authors: zurbriggen r. Vaccine. 2009 Oct 30;27(46):6415-9. doi: 10.1016/j.vaccine.2009.06.019. Epub 2009 Jun 24. Vaccine. 2009. PMID: 19559121

8

Virosome-based active immunization targets soluble amyloid species rather than plaques in a transgenic mouse model of Alzheimer's disease.

Zurbriggen R, Amacker M, Kammer AR, Westerfeld N, Borghgraef P, Van Leuven F, Van der Auwera I, Wera S. Zurbriggen R, et al. J Mol Neurosci. 2005;27(2):157-66. doi: 10.1385/JMN:27:2:157. J Mol Neurosci. 2005. PMID: 16186626

9

Virosome-mediated delivery of tumor antigen to plasmacytoid dendritic cells.

Angel J, Chaperot L, Molens JP, Mezin P, Amacker M, Zurbriggen R, Grichine A, Plumas J. Angel J, et al. Among authors: zurbriggen r. Vaccine. 2007 May 10;25(19):3913-21. doi: 10.1016/j.vaccine.2007.01.101. Epub 2007 Feb 15. Vaccine. 2007. PMID: 17336432

10

Influenza virosomes as a combined vaccine carrier and adjuvant system for prophylactic and therapeutic immunizations.

Moser C, Amacker M, Kammer AR, Rasi S, Westerfeld N, Zurbriggen R. Moser C, et al. Among authors: zurbriggen r. Expert Rev Vaccines. 2007 Oct;6(5):711-21. doi: 10.1586/14760584.6.5.711. Expert Rev Vaccines. 2007. PMID: 17931152 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

79 results

Search Page

Filters